Lockheed Martin stock nears a fresh high after Jefferies target hike as earnings loom

Lockheed Martin stock nears a fresh high after Jefferies target hike as earnings loom

New York, Jan 13, 2026, 13:55 ET — Regular session

  • Lockheed Martin shares climbed roughly 1%, hitting a high of $564 during afternoon trading
  • Jefferies raised its price target to $540 while maintaining a Hold rating, citing concerns over a possibly weak 2026 outlook
  • Investors are focusing on the Jan. 29 results for insights into 2026 margins, cash flow, and production ramps

Shares of Lockheed Martin Corp climbed roughly 1% on Tuesday, reaching $556.55 in afternoon trading and earlier hitting a high of $564.00. Jefferies raised its price target to $540 from $500 but maintained a “Hold” rating, cautioning that 2026 revenue and EPS guidance may “slightly disappoint.” (TipRanks)

Timing is crucial. Defense stocks are moving based on policy signals and whether major contractors can boost production without sacrificing margins. Investors have been swift to punish any setbacks or delays.

Washington is ramping up efforts on the supply chain front. The Pentagon announced a $1 billion investment in L3Harris Technologies’ rocket-motor division to increase output of propulsion systems for missiles like Tomahawks and Patriot interceptors. (Reuters)

Lockheed on Tuesday announced it has delivered its 350th MH-60R “Romeo” helicopter to the U.S. Navy, marking a key milestone for its Sikorsky unit. Ali Ruwaih, vice president of maritime systems, said, “We are proud to support the U.S. Navy.” (Media – Lockheed Martin)

Lockheed revealed yesterday that Secretary of War Pete Hegseth visited its Fort Worth F-35 production line, meeting with employees. “We can’t deter the next conflict without the skills and capabilities you have,” Hegseth said. CEO Jim Taiclet described the F-35 as “the most advanced multi-mission fighter jet in the world.” (Media – Lockheed Martin)

Analysts remain divided on the next move. Jefferies highlighted potential triggers like fresh awards and program acceleration but warned Lockheed’s 2026 forecast might be conservative. One recent note also tagged the stock as a bit pricey compared to its “fair value” estimate. (Investing.com)

Risks stretch beyond the usual guidance. The Pentagon’s shift toward taking equity-like stakes in suppliers has raised eyebrows over potential conflicts and competition issues. Such scrutiny could easily rebound on the prime contractors who rely on those suppliers. (Financial Times)

Lockheed’s set to release fourth-quarter and full-year results on Jan. 29, with a webcast kicking off at 8:30 a.m. ET. Investors will zero in on the 2026 outlook, focusing on margins, cash flow, and how quickly their high-demand programs are advancing. (Spacepolicyonline)

Stock Market Today

  • ABBV inks drug pricing deal with Trump, joins PD-1xVEGF bandwagon
    January 13, 2026, 2:32 PM EST. AbbVie said it signed a U.S. pricing agreement with the Trump administration to cut list prices to match those in comparable developed markets, backing the MFN proposal. The deal includes a three-year exemption from import tariffs on pharmaceutical ingredients if AbbVie expands U.S. manufacturing, and a pledge to invest $100 billion over the next decade in domestic R&D and capital. The government says 16 of 17 large drugmakers have reached similar accords; Regeneron remains in talks. In a separate release, AbbVie agreed to an exclusive license with RemeGen for its PD-1xVEGF bispecific, RC148. AbbVie will pay an upfront $650 million and up to $4.95 billion in milestones, plus royalties, for rights outside Greater China. RC148 is in phase II in China, with potential in NSCLC and CRC. Competitors include Summit, BioNTech/Bristol Myers, Merck and Pfizer pursuing PD-1/VEGF programs.
Gold stocks rise as gold price hits record after U.S. CPI; Newmont, Agnico gain
Previous Story

Gold stocks rise as gold price hits record after U.S. CPI; Newmont, Agnico gain

Bitcoin price today nears $93,500 as Senate crypto bill lifts Coinbase, Strategy stock
Next Story

Bitcoin price today nears $93,500 as Senate crypto bill lifts Coinbase, Strategy stock

Go toTop